282 related articles for article (PubMed ID: 28657664)
1. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Gao Y; Lin P; Lydon JP; Li Q
J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of transforming growth factor Beta receptor 1 in the mouse uterus impairs uterine morphology and function.
Gao Y; Duran S; Lydon JP; DeMayo FJ; Burghardt RC; Bayless KJ; Bartholin L; Li Q
Biol Reprod; 2015 Feb; 92(2):34. PubMed ID: 25505200
[TBL] [Abstract][Full Text] [Related]
3. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma.
Monsivais D; Peng J; Kang Y; Matzuk MM
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3883-3892. PubMed ID: 30655341
[TBL] [Abstract][Full Text] [Related]
4. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.
Hall B; Nakashima H; Sun ZJ; Sato Y; Bian Y; Husain SR; Puri RK; Kulkarni AB
J Transl Med; 2013 Feb; 11():45. PubMed ID: 23421960
[TBL] [Abstract][Full Text] [Related]
5. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
[TBL] [Abstract][Full Text] [Related]
6. Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.
Bajwa P; Nielsen S; Lombard JM; Rassam L; Nahar P; Rueda BR; Wilkinson JE; Miller RA; Tanwar PS
Oncotarget; 2017 Jan; 8(5):7265-7275. PubMed ID: 27980219
[TBL] [Abstract][Full Text] [Related]
7. Mutual contribution of Pten and estrogen to endometrial carcinogenesis in a PtenloxP/loxP mouse model.
Saito F; Tashiro H; To Y; Ohtake H; Ohba T; Suzuki A; Katabuchi H
Int J Gynecol Cancer; 2011 Nov; 21(8):1343-9. PubMed ID: 21989218
[TBL] [Abstract][Full Text] [Related]
8. The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten.
Liang X; Daikoku T; Terakawa J; Ogawa Y; Joshi AR; Ellenson LH; Sun X; Dey SK
PLoS Genet; 2018 Aug; 14(8):e1007630. PubMed ID: 30142194
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
10. Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.
Dosil MA; Mirantes C; Eritja N; Felip I; Navaridas R; Gatius S; Santacana M; Colàs E; Moiola C; Schoenenberger JA; Encinas M; Garí E; Matias-Guiu X; Dolcet X
J Pathol; 2017 Jun; 242(2):152-164. PubMed ID: 28349562
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
12. A novel mouse model of testicular granulosa cell tumors.
Fang X; Ni N; Gao Y; Vincent DF; Bartholin L; Li Q
Mol Hum Reprod; 2018 Jul; 24(7):343-356. PubMed ID: 29788434
[TBL] [Abstract][Full Text] [Related]
13. Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.
Wang X; Wendel JRH; Emerson RE; Broaddus RR; Creighton CJ; Rusch DB; Buechlein A; DeMayo FJ; Lydon JP; Hawkins SM
Oncogene; 2020 Oct; 39(40):6286-6299. PubMed ID: 32843721
[TBL] [Abstract][Full Text] [Related]
14. Disruption of postnatal folliculogenesis and development of ovarian tumor in a mouse model with aberrant transforming growth factor beta signaling.
Gao Y; Fang X; Vincent DF; Threadgill DW; Bartholin L; Li Q
Reprod Biol Endocrinol; 2017 Dec; 15(1):94. PubMed ID: 29221447
[TBL] [Abstract][Full Text] [Related]
15. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
[TBL] [Abstract][Full Text] [Related]
16. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
[TBL] [Abstract][Full Text] [Related]
17. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
18. Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
van der Zee M; Jia Y; Wang Y; Heijmans-Antonissen C; Ewing PC; Franken P; DeMayo FJ; Lydon JP; Burger CW; Fodde R; Blok LJ
J Pathol; 2013 May; 230(1):48-58. PubMed ID: 23288720
[TBL] [Abstract][Full Text] [Related]
19. TGFBR1 and cancer susceptibility.
Pasche B; Pennison MJ; Jimenez H; Wang M
Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor β receptor type 1 is essential for female reproductive tract integrity and function.
Li Q; Agno JE; Edson MA; Nagaraja AK; Nagashima T; Matzuk MM
PLoS Genet; 2011 Oct; 7(10):e1002320. PubMed ID: 22028666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
